{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:51:53Z","timestamp":1790707913106,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770557"],"award-info":[{"award-number":["81770557"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070684"],"award-info":[{"award-number":["82070684"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Natural Science Fund for Outstanding","award":["2020B151502067"],"award-info":[{"award-number":["2020B151502067"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10620-021-07015-0","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T09:31:16Z","timestamp":1622799076000},"page":"2232-2243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Adiponectin Alleviates Intestinal Fibrosis by Enhancing AMP-Activated Protein Kinase Phosphorylation"],"prefix":"10.1007","volume":"67","author":[{"given":"Minghao","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longyang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8895-7792","authenticated-orcid":false,"given":"Lei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"key":"7015_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00054725-200207000-00002","volume":"8","author":"J Cosnes","year":"2002","unstructured":"Cosnes J, Cattan S, Blain A et al. Long-term evolution of disease behavior of Crohn\u2019s disease. Inflamm Bowel Dis. 2002;8:244\u2013250.","journal-title":"Inflamm Bowel Dis."},{"key":"7015_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1572-0241.2000.01779.x","volume":"95","author":"RD Cohen","year":"2000","unstructured":"Cohen RD, Larson LR, Roth JM, Becker RV, Mummert LL. The cost of hospitalization in Crohn\u2019s disease. Am J Gastroenterol. 2000;95:524\u2013530.","journal-title":"Am J Gastroenterol."},{"key":"7015_CR3","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/gut.49.6.777","volume":"49","author":"E Louis","year":"2001","unstructured":"Louis E, Collard A, Oger AF et al. Behaviour of Crohn\u2019s disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777\u2013782.","journal-title":"Gut."},{"key":"7015_CR4","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/cells8060628","volume":"8","author":"P Eder","year":"2019","unstructured":"Eder P, Adler M, Dobrowolska A, Kamhieh-Milz J, Witowski J. The role of adipose tissue in the pathogenesis and therapeutic outcomes of inflammatory bowel disease. Cells-Basel. 2019;8:628.","journal-title":"Cells-Basel."},{"key":"7015_CR5","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/biom9120780","volume":"9","author":"J Bilski","year":"2019","unstructured":"Bilski J, Mazur-Bialy A, Wojcik D et al. Role of obesity, mesenteric adipose tissue, and adipokines in inflammatory bowel diseases. Biomolecules. 2019;9:780.","journal-title":"Biomolecules."},{"key":"7015_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00011-018-1155-6","volume":"67","author":"Q Zhao","year":"2018","unstructured":"Zhao Q, Liu Y, Tan L, Yan L, Zuo X. Adiponectin administration alleviates DSS-induced colonic inflammation in Caco-2 cells and mice. Inflamm Res. 2018;67:663\u2013670.","journal-title":"Inflamm Res."},{"key":"7015_CR7","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1681\/ASN.2013030217","volume":"24","author":"J Yang","year":"2013","unstructured":"Yang J, Lin SC, Chen G et al. Adiponectin promotes monocyte-to-fibroblast transition in renal fibrosis. J Am Soc Nephrol. 2013;24:1644\u20131659.","journal-title":"J Am Soc Nephrol."},{"key":"7015_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1042\/BJ20102148","volume":"440","author":"JA Handy","year":"2011","unstructured":"Handy JA, Fu PP, Kumar P et al. Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis. Biochem J. 2011;440:385\u2013395.","journal-title":"Biochem J."},{"key":"7015_CR9","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3389\/fimmu.2018.01974","volume":"9","author":"C Weidinger","year":"2018","unstructured":"Weidinger C, Ziegler JF, Letizia M, Schmidt F, Siegmund B. Adipokines and their role in intestinal inflammation. Front Immunol. 2018;9:1974.","journal-title":"Front Immunol."},{"key":"7015_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/cvr\/cvq335","volume":"89","author":"M Konishi","year":"2011","unstructured":"Konishi M, Haraguchi G, Ohigashi H et al. Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation. Cardiovasc Res. 2011;89:309\u2013319.","journal-title":"Cardiovasc Res."},{"key":"7015_CR11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3390\/cells8070721","volume":"8","author":"U Baranyi","year":"2019","unstructured":"Baranyi U, Winter B, Gugerell A et al. Primary human fibroblasts in culture switch to a Myofibroblast-Like phenotype independently of TGF beta. Cells-Basel. 2019;8:721.","journal-title":"Cells-Basel."},{"key":"7015_CR12","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s10620-018-5082-8","volume":"63","author":"L Lian","year":"2018","unstructured":"Lian L, Huang Q, Zhang L et al. Anti-fibrogenic potential of mesenchymal stromal cells in treating fibrosis in Crohn\u2019s disease. Dig Dis Sci. 2018;63:1821\u20131834. https:\/\/doi.org\/10.1007\/s10620-018-5082-8.","journal-title":"Dig Dis Sci."},{"key":"7015_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","volume":"86","author":"PE Shrout","year":"1979","unstructured":"Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420\u2013428.","journal-title":"Psychol Bull."},{"key":"7015_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1053\/j.gastro.2016.09.047","volume":"152","author":"F Rieder","year":"2017","unstructured":"Rieder F, Fiocchi C, Rogler G. Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases. Gastroenterology. 2017;152:340\u2013350.","journal-title":"Gastroenterology."},{"key":"7015_CR15","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1053\/j.gastro.2018.11.029","volume":"156","author":"K Scheibe","year":"2019","unstructured":"Scheibe K, Kersten C, Schmied A et al. Inhibiting interleukin 36 receptor signaling reduces fibrosis in mice with chronic intestinal inflammation. Gastroenterology. 2019;156:1082\u20131097.","journal-title":"Gastroenterology."},{"key":"7015_CR16","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1053\/j.gastro.2017.06.013","volume":"153","author":"T Holvoet","year":"2017","unstructured":"Holvoet T, Devriese S, Castermans K et al. Treatment of intestinal fibrosis in experimental inflammatory bowel disease by the pleiotropic actions of a local rho kinase inhibitor. Gastroenterology 2017;153:1054\u20131067.","journal-title":"Gastroenterology"},{"key":"7015_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/0002-9343(52)90025-9","volume":"13","author":"BB Crohn","year":"1952","unstructured":"Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. Am J Med. 1952;13:583\u2013590.","journal-title":"Am J Med."},{"key":"7015_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ibd.21413","volume":"17","author":"I Olivier","year":"2011","unstructured":"Olivier I, Theodorou V, Valet P et al. Is Crohn\u2019s creeping fat an adipose tissue? Inflamm Bowel Dis. 2011;17:747\u2013757.","journal-title":"Inflamm Bowel Dis."},{"key":"7015_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2013.12.012","volume":"156","author":"ED Rosen","year":"2014","unstructured":"Rosen ED, Spiegelman BM. What we talk about when we talk about fat. Cell. 2014;156:20\u201344.","journal-title":"Cell."},{"key":"7015_CR20","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00408-015-9793-8","volume":"193","author":"AR de Lima","year":"2015","unstructured":"de Lima AR, Da CSAL, Costa C, Rufino R. Adiponectin in asthma and obesity: protective agent or risk factor for more severe disease? Lung. 2015;193:749\u2013755.","journal-title":"Lung."},{"key":"7015_CR21","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1210\/en.2014-1738","volume":"156","author":"Z Jin","year":"2015","unstructured":"Jin Z, Du Y, Schwaid AG et al. Maternal adiponectin controls milk composition to prevent neonatal inflammation. Endocrinology. 2015;156:1504\u20131513.","journal-title":"Endocrinology."},{"key":"7015_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1046\/j.1365-2249.2000.01227.x","volume":"120","author":"E Louis","year":"2000","unstructured":"Louis E, Ribbens C, Godon A et al. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol. 2000;120:241\u2013246.","journal-title":"Clin Exp Immunol."},{"key":"7015_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/gut.47.1.57","volume":"47","author":"RB Heuschkel","year":"2000","unstructured":"Heuschkel RB, MacDonald TT, Monteleone G et al. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease. Gut. 2000;47:57\u201362.","journal-title":"Gut."},{"key":"7015_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/ncpneph0093","volume":"2","author":"EG Neilson","year":"2006","unstructured":"Neilson EG. Mechanisms of disease: fibroblasts: a new look at an old problem. Nat Clin Pract Nephrol. 2006;2:101\u2013108.","journal-title":"Nat Clin Pract Nephrol."},{"key":"7015_CR25","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/eurheartj\/ehy188","volume":"40","author":"P Rodriguez","year":"2019","unstructured":"Rodriguez P, Sassi Y, Troncone L et al. Deletion of delta-like 1 homologue accelerates fibroblast-myofibroblast differentiation and induces myocardial fibrosis. Eur Heart J. 2019;40:967\u2013978.","journal-title":"Eur Heart J."},{"key":"7015_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12931-020-1300-y","volume":"21","author":"P Liu","year":"2020","unstructured":"Liu P, Miao K, Zhang L et al. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-beta-induced fibroblast to myofibroblast differentiation. Respir Res. 2020;21:58.","journal-title":"Respir Res."},{"key":"7015_CR27","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/ibd\/izx008","volume":"24","author":"M Truffi","year":"2018","unstructured":"Truffi M, Sorrentino L, Monieri M et al. Inhibition of fibroblast activation protein restores a balanced extracellular matrix and reduces fibrosis in Crohn\u2019s disease strictures ex vivo. Inflamm Bowel Dis. 2018;24:332\u2013345.","journal-title":"Inflamm Bowel Dis."},{"key":"7015_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/MIB.0000000000000295","volume":"21","author":"LH Kurahara","year":"2015","unstructured":"Kurahara LH, Sumiyoshi M, Aoyagi K et al. Intestinal myofibroblast TRPC6 channel may contribute to stenotic fibrosis in Crohn\u2019s disease. Inflamm Bowel Dis. 2015;21:496\u2013506.","journal-title":"Inflamm Bowel Dis."},{"key":"7015_CR29","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/ecco-jcc\/jjy036","volume":"12","author":"JR de Bruyn","year":"2018","unstructured":"de Bruyn JR, van den Brink GR, Steenkamer J et al. Fibrostenotic phenotype of myofibroblasts in crohn\u2019s disease is dependent on tissue stiffness and reversed by LOX inhibition. J Crohns Colitis. 2018;12:849\u2013859.","journal-title":"J Crohns Colitis."},{"key":"7015_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.kint.2017.04.033","volume":"93","author":"Y Wang","year":"2018","unstructured":"Wang Y, Jia L, Hu Z et al. AMP-activated protein kinase\/myocardin-related transcription factor-A signaling regulates fibroblast activation and renal fibrosis. Kidney Int. 2018;93:81\u201394.","journal-title":"Kidney Int."},{"key":"7015_CR31","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/gut.2004.046516","volume":"54","author":"K Yamamoto","year":"2005","unstructured":"Yamamoto K, Kiyohara T, Murayama Y et al. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn\u2019s disease. Gut. 2005;54:789\u2013796.","journal-title":"Gut."},{"key":"7015_CR32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/00054725-200606000-00005","volume":"12","author":"G Paul","year":"2006","unstructured":"Paul G, Schaffler A, Neumeier M et al. Profiling adipocytokine secretion from creeping fat in Crohn\u2019s disease. Inflamm Bowel Dis. 2006;12:471\u2013477.","journal-title":"Inflamm Bowel Dis."},{"key":"7015_CR33","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cell.2020.09.009","volume":"183","author":"C Ha","year":"2020","unstructured":"Ha C, Martin A, Sepich-Poore GD et al. Translocation of viable gut microbiota to mesenteric adipose drives formation of creeping fat in humans. Cell. 2020;183:666\u2013683.","journal-title":"Cell."},{"key":"7015_CR34","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.4049\/jimmunol.154.11.5611","volume":"154","author":"KW Beagley","year":"1995","unstructured":"Beagley KW, Fujihashi K, Lagoo AS et al. Differences in intraepithelial lymphocyte T cell subsets isolated from murine small versus large intestine. J Immunol. 1995;154:5611\u20135619.","journal-title":"J Immunol."},{"key":"7015_CR35","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.3389\/fimmu.2019.02269","volume":"10","author":"C Zhou","year":"2019","unstructured":"Zhou C, Qiu Y, Yang H. CD4CD8alphaalpha IELs: they have something to say. Front Immunol. 2019;10:2269.","journal-title":"Front Immunol."},{"key":"7015_CR36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1365-2249.1995.tb03835.x","volume":"102","author":"TT MacDonald","year":"1995","unstructured":"MacDonald TT. Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease (IBD). Clin Exp Immunol. 1995;102:445\u2013447.","journal-title":"Clin Exp Immunol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07015-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-07015-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07015-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T14:08:21Z","timestamp":1699106901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-07015-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["7015"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-07015-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,19]]},"assertion":[{"value":"1 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest regarding the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experiments were carried out under a protocol approved by the Ethics Committee of the Sixth Affiliated Hospital of Sun Yat-sen University. The institutional and national guide for the care and use of laboratory animals was followed in the animal experiments, and it was approved by the Institutional Animal Care and Use Committee of the Sixth Affiliated Hospital of Sun Yat-Sen University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All clinical samples collected and analyzed in this study were approved by the patients and all patients signed informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}